March 2023 – Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications | Hovione

March 2023 – Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications | Hovione

de.MO

March Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications

Avalon’s client, Laxxon Medical has formed an agreement with Hovione regarding cGMP production of 3D screem printed pharmaceutical applications. This partnership combines Laxxon´s expertise in 3D screen printing, based on their SPID®-Technology, with Hovione’s product & process development, engineering and manufacturing expertise in pharmaceutical applications.

For the full article, follow this (LINK).

June 2023 – Avalon Securities Arranges $35 Million Working Capital Facility for Newly Formed Entity Bringing Jobs from Asia to the United States.

June 2023 – Avalon Securities Arranges $35 Million Working Capital Facility for Newly Formed Entity Bringing Jobs from Asia to the United States.
March 2023 – SmartLabs Announces Launch of its Most Advanced Managed Research Center

March 2023 – SmartLabs Announces Launch of its Most Advanced Managed Research Center